Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma (Q34627911)

3 August 2017

title

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma (English)

1 reference

3 August 2017

0 references

1 reference

K Linton

3

0 references

Caroline Dive

object named as

C Dive

12

0 references

John Radford

object named as

J Radford

11

0 references

author name string

A Greystoke

1

1 reference

3 August 2017

J P B O'Connor

2

1 reference

3 August 2017

M B Taylor

4

1 reference

3 August 2017

J Cummings

5

1 reference

3 August 2017

T Ward

6

1 reference

3 August 2017

F Maders

7

1 reference

3 August 2017

A Hughes

8

1 reference

3 August 2017

M Ranson

9

1 reference

3 August 2017

T M Illidge

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

18 January 2011

1 reference

British Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

104

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

719-725

1 reference

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Clinical relevance of circulating nucleosomes in cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Biomarker method validation in anticancer drug development

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049589

Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy.

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606082

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606082

Optimisation of circulating biomarkers of cell death for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606082

Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606082

Use of flt3 ligand to evaluate residual hematopoiesis after heterogeneous irradiation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606082

Radiation-induced increase in plasma Flt3 ligand concentration in mice: evidence for the implication of several cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606082

Elevated levels of interleukin-1?-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606082

Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia

21 January 2018

1 reference

12 December 2020

Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study

1 reference

12 December 2020

Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma

1 reference

12 December 2020

Crucial role of FLT3 ligand in immune reconstitution after bone marrow transplantation and high-dose chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6606082

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference